InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Pruzanski Mark, Director. Officer active across 2 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 13 filings have been published. Breakdown: 0 buy · 2 sells. Activity tracked since 30 April 2021. The latest transaction was filed on 8 November 2023 (U). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Pruzanski Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
618,894 shares@ US$19.0088.5% of flowCommon StockSEC:0001104659-23-117094:0
6,138 shares@ US$17.210.8% of flowCommon StockSEC:0001104659-21-145908:0
6,138 shares@ US$16.860.8% of flowCommon StockSEC:0001104659-21-132983:0
6,136 shares@ US$14.850.7% of flowCommon StockSEC:0001104659-21-122560:0
6,138 shares@ US$14.910.7% of flowCommon StockSEC:0001104659-21-112144:0
6,138 shares@ US$17.280.8% of flowCommon StockSEC:0001104659-21-099031:0
6,136 shares@ US$19.970.9% of flowCommon StockSEC:0001104659-21-088399:0
6,138 shares@ US$16.630.7% of flowCommon StockSEC:0001104659-21-075896:0
6,138 shares@ US$19.780.9% of flowCommon StockSEC:0001104659-21-061181:0
23,300 sharesCommon StockSEC:0001144204-16-081816:0
4,868 sharesCommon StockSEC:0001144204-16-074237:0
2,001 sharesCommon StockSEC:0001144204-16-074237:1
125 sharesCommon StockSEC:0001144204-16-074237:2
13 of 13 declarations
About Pruzanski Mark
Mark Pruzanski is an executive at INTERCEPT PHARMACEUTICALS, INC.
